[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"news-aggregator-centessa-pharmaceuticals-nasda3301924ee0-303b-7c54-959d-f5181d4e5bf5":3},{"id":4,"timestamp":5,"title":6,"content":7,"link":8,"preview":9,"tags":10,"predictedTags":10,"showTags":10,"source":11,"reactions":12,"selfReactions":13,"logo":14,"sourceId":15,"sourceUserId":16,"asset":17,"tagsCategories":18,"totalComments":19,"lang":20,"unique_views_count":21},"centessa-pharmaceuticals-nasda3301924ee0-303b-7c54-959d-f5181d4e5bf5","1727898722000","Centessa Pharmaceuticals (NASDAQ:CNTA) Trading Down 3.3%","Centessa Pharmaceuticals (NASDAQ:CNTA) Stock Price Down 3.3%","https://www.marketbeat.com/instant-alerts/nasdaq-cnta-percent-decline-2024-10-02/","https://www.marketbeat.com/images/marketbeat-logo-1200-1200.jpg?v=1","[]","33",[],[],"https://toscalepublic.s3.eu-west-2.amazonaws.com/images/news-feeds/sources/market-beat.png","Market Beat",null,"","[\"Other\"]","0","EN","1"]